Vetamer Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$1.76M |
| 2 |
Bath & Body Works
BBWI
|
+$1.61M |
| 3 |
Wells Fargo
WFC
|
+$1.57M |
| 4 |
Cintas
CTAS
|
+$1.48M |
| 5 |
Equifax
EFX
|
+$1.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Toast
TOST
|
+$1.88M |
| 2 |
Mastercard
MA
|
+$1.84M |
| 3 |
First Citizens BancShares
FCNCA
|
+$1.84M |
| 4 |
Amazon
AMZN
|
+$1.83M |
| 5 |
ServiceNow
NOW
|
+$1.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 37.39% |
| 2 | Technology | 27.91% |
| 3 | Consumer Discretionary | 10.47% |
| 4 | Industrials | 9.52% |
| 5 | Communication Services | 4.66% |
Similar funds
Vetamer Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Vetamer Capital Management held 68 positions worth $73.3M, down 19% from $90.7M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Vetamer Capital Management withdrew a net $21.5M in Q4 2022, closing 10 positions and reducing 31 holdings. Its most notable exit was Charles Schwab, an estimated $1.59M position sold in full.
By sector, the portfolio is most concentrated in Financials at 37% of assets, down from 39% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Vetamer Capital Management opened a new position in Thermo Fisher Scientific worth $1.83M.
- Vetamer Capital Management's largest Q4 2022 buy was Thermo Fisher Scientific: 3,327 shares worth $1.83M.
- Vetamer Capital Management added most to Wells Fargo in Q4 2022, an estimated $1.57M increase.
- Vetamer Capital Management's biggest Q4 2022 reduction was Toast, cutting an estimated $1.88M.
- Vetamer Capital Management fully exited Charles Schwab in Q4 2022, selling an estimated $1.59M.
- Vetamer Capital Management's ten largest holdings make up 38% of its $73.3M portfolio in Q4 2022.
- Vetamer Capital Management opened 15 new positions and closed 10 in Q4 2022.
- Vetamer Capital Management's portfolio value fell 19% quarter-over-quarter to $73.3M.
Based on Vetamer Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.